Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $3,815 - $4,303
17 New
17 $3,000
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $3,069 - $3,395
-14 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $2,784 - $3,186
14 New
14 $3.15 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Absolute Capital Management, LLC Portfolio

Follow Absolute Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Absolute Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Absolute Capital Management, LLC with notifications on news.